Clinical Trials Directory

Trials / Completed

CompletedNCT01829932

The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Queen's University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Irritable bowel syndrome (IBS) is a chronic gastrointestinal illness of unknown cause whose symptoms include abdominal pain, bloating and altered bowel pattern. Diet has been shown to influence the bacteria gut interaction. Our aim is to determine if components of the diet affect IBS symptoms by changing the bacteria gut interaction. In particular, we will measure whether after being on a diet high or low on certain factors there is a change in the timing and amount of hydrogen and methane produced by bacteria digesting lactulose and on IBS symptom severity.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFactor Altered Diet

Timeline

Start date
2013-04-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2013-04-11
Last updated
2015-10-14

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01829932. Inclusion in this directory is not an endorsement.